Relevium Closes Private Placement Financing

MONTREAL, June 11, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has closed a non-brokered private placement financing for a total of...

Relevium Provides Corporate Update on Its Medical Cannabis Strategy

MONTREAL, June 03, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s positioning and strategy regarding medical cannabis...

Relevium Acquires Exclusive Licence From California Based Cannakids®

MONTREAL, May 30, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary Biocannabix Health Corporation Inc., has completed...

Albertus P. Engelbrecht Files Early Warning Report

May 21, 2019 (TheNewswire.ca) — (via TheNewswire) MONTREAL, QUEBEC / TheNewswire / May 21, 2019 – Mr. Albertus P. Engelbrecht on 9 Heron Street Durbanville, Cape Town, 7550, Western Cape, South Africa (the “Shareholder”) announces the filing of...